PixarBio Corporation (PXRB) est une société cotée en bourse dans le Consommation Cyclique secteur, opérant dans le Personal Products & Services secteur d'activité. Le PDG actuel est Francis M. Reynolds.
PXRB a date d'introduction en bourse 2023-06-27, 30 employés à temps plein, cotée sur le Other OTC, une capitalisation boursière de $82.00.
PixarBio Corporation, a specialty pharmaceutical/biotechnology company, focuses on the pre-clinical and clinical development of neurological drug delivery systems for post-operative pain. The company researches and develops delivery systems for drugs, devices, or biologics to treat pain, epilepsy, epilepsy, Parkinson's disease, and spinal cord injury. Its principal product platform is NeuroRelease for the therapeutic release of non-opiate drugs for post-operative, acute, and chronic pain in pre-clinical models. The company was founded in 2014 and is based in Medford, Massachusetts.
